Successful Treatment of Mycoplasma hominis Meningitis, Diagnosed Using Real-Time Polymerase Chain Reaction, with Ciprofloxacin in a Neonate
Mycoplasma hominis can cause life-threatening central nervous system infections in neonates following intrauterine infection or during delivery. In newborns, the diagnosis and treatment of M. hominis meningitis are challenging, because cultures are often negative and the bacterium is not susceptible to empirical antibiotics. Herein, we describe a case of neonatal M. hominis meningitis diagnosed using real-time polymerase chain reaction (RT-PCR) and treated with ciprofloxacin. The patient was a 3-day-old female hospitalized for a fever and lethargy. Her blood laboratory findings were non-specific; cerebrospinal fluid (CSF) examination showed a white blood cell count of 580/μL and indicated meningitis. Her symptoms could not be controlled with empirical antibiotics. Urine culture on a special medium revealed ciprofloxacin-susceptible M. hominis. Furthermore, the RT-PCR performed with the CSF sample revealed M. hominis. Therefore, the patient was administered ciprofloxacin; after 2 days, the fever subsided. The patient was discharged on day 30 without complications..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Neonatal Medicine - 27(2020), 3, Seite 147-150 |
Sprache: |
Englisch ; Koreanisch |
---|
Beteiligte Personen: |
Iktae Gwon [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Ciprofloxacin |
---|
doi: |
10.5385/nm.2020.27.3.147 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ016495314 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ016495314 | ||
003 | DE-627 | ||
005 | 20230310082911.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5385/nm.2020.27.3.147 |2 doi | |
035 | |a (DE-627)DOAJ016495314 | ||
035 | |a (DE-599)DOAJ61557d5f753c49a4b847a2c218556231 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a kor | ||
050 | 0 | |a RJ1-570 | |
100 | 0 | |a Iktae Gwon |e verfasserin |4 aut | |
245 | 1 | 0 | |a Successful Treatment of Mycoplasma hominis Meningitis, Diagnosed Using Real-Time Polymerase Chain Reaction, with Ciprofloxacin in a Neonate |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Mycoplasma hominis can cause life-threatening central nervous system infections in neonates following intrauterine infection or during delivery. In newborns, the diagnosis and treatment of M. hominis meningitis are challenging, because cultures are often negative and the bacterium is not susceptible to empirical antibiotics. Herein, we describe a case of neonatal M. hominis meningitis diagnosed using real-time polymerase chain reaction (RT-PCR) and treated with ciprofloxacin. The patient was a 3-day-old female hospitalized for a fever and lethargy. Her blood laboratory findings were non-specific; cerebrospinal fluid (CSF) examination showed a white blood cell count of 580/μL and indicated meningitis. Her symptoms could not be controlled with empirical antibiotics. Urine culture on a special medium revealed ciprofloxacin-susceptible M. hominis. Furthermore, the RT-PCR performed with the CSF sample revealed M. hominis. Therefore, the patient was administered ciprofloxacin; after 2 days, the fever subsided. The patient was discharged on day 30 without complications. | ||
650 | 4 | |a mycoplasma hominis | |
650 | 4 | |a meningitis | |
650 | 4 | |a infant, newborn | |
650 | 4 | |a real-time polymerase chain reaction | |
650 | 4 | |a ciprofloxacin | |
653 | 0 | |a Pediatrics | |
700 | 0 | |a Woo Sun Song |e verfasserin |4 aut | |
700 | 0 | |a Yong-Hak Sohn |e verfasserin |4 aut | |
700 | 0 | |a Seung Yeon Kim |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Neonatal Medicine |d Korean Society of Neonatology, 2019 |g 27(2020), 3, Seite 147-150 |w (DE-627)DOAJ000097071 |x 22879803 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2020 |g number:3 |g pages:147-150 |
856 | 4 | 0 | |u https://doi.org/10.5385/nm.2020.27.3.147 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/61557d5f753c49a4b847a2c218556231 |z kostenfrei |
856 | 4 | 0 | |u http://www.neo-med.org/upload/pdf/nm-2020-27-3-147.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2287-9412 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2287-9803 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 27 |j 2020 |e 3 |h 147-150 |